Canandaigua National Bank & Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.93M | Buy |
+27,540
| New | +$5.93M | 0.58% | 36 |
|
|
2025
Q4 | $6.5M | Sell |
28,464
-857
| -3% | -$195K | 0.58% | 35 |
|
|
2025
Q3 | $6.79M | Sell |
29,321
-1,617
| -5% | -$329K | 0.6% | 35 |
|
|
2025
Q2 | $5.74M | Buy |
30,938
+422
| +1% | +$78.4K | 0.53% | 41 |
|
|
2025
Q1 | $6.39M | Sell |
30,516
-1,098
| -3% | -$213K | 0.64% | 35 |
|
|
2024
Q4 | $5.62M | Sell |
31,614
-497
| -2% | -$91.4K | 0.55% | 37 |
|
|
2024
Q3 | $6.34M | Sell |
32,111
-847
| -3% | -$158K | 0.6% | 38 |
|
|
2024
Q2 | $5.65M | Buy |
32,958
+1,823
| +6% | +$302K | 0.61% | 34 |
|
|
2024
Q1 | $5.67M | Sell |
31,135
-989
| -3% | -$170K | 0.84% | 24 |
|
|
2023
Q4 | $4.98M | Sell |
32,124
-1,608
| -5% | -$234K | 0.77% | 32 |
|
|
2023
Q3 | $5.03M | Buy |
33,732
+5,696
| +20% | +$836K | 0.81% | 31 |
|
|
2023
Q2 | $3.78M | Sell |
28,036
-442
| -2% | -$64.8K | 0.61% | 42 |
|
|
2023
Q1 | $4.54M | Buy |
+28,478
| New | +$4.35M | 0.76% | 33 |
|
|
2020
Q1 | $2.42M | Sell |
31,824
-269
| -0.8% | -$22.9K | 0.51% | 59 |
|
|
2019
Q4 | $2.84M | Sell |
32,093
-991
| -3% | -$82.3K | 0.48% | 64 |
|
|
2019
Q3 | $2.5M | Buy |
33,084
+1,900
| +6% | +$130K | 0.44% | 64 |
|
|
2019
Q2 | $2.27M | Buy |
31,184
+245
| +0.8% | +$19.3K | 0.42% | 66 |
|
|
2019
Q1 | $2.49M | Sell |
30,939
-8,105
| -21% | -$663K | 0.48% | 63 |
|
|
2018
Q4 | $3.6M | Sell |
39,044
-820
| -2% | -$72.1K | 0.76% | 33 |
|
|
2018
Q3 | $3.77M | Buy |
39,864
+1,673
| +4% | +$159K | 0.67% | 38 |
|
|
2018
Q2 | $3.54M | Buy |
38,191
+2,238
| +6% | +$219K | 0.68% | 41 |
|
|
2018
Q1 | $3.4M | Buy |
35,953
+2,212
| +7% | +$243K | 0.43% | 60 |
|
|
2017
Q4 | $3.26M | Sell |
33,741
-231
| -0.7% | -$21.8K | 0.59% | 48 |
|
|
2017
Q3 | $3.02M | Sell |
33,972
-970
| -3% | -$73.8K | 0.57% | 50 |
|
|
2017
Q2 | $2.53M | Buy |
34,942
+582
| +2% | +$39.1K | 0.52% | 54 |
|
|
2017
Q1 | $2.24M | Sell |
34,360
-667
| -2% | -$41.9K | 0.66% | 41 |
|
|
2016
Q4 | $2.19M | Buy |
35,027
+1,252
| +4% | +$76.4K | 0.66% | 39 |
|
|
2016
Q3 | $2.13M | Sell |
33,775
-817
| -2% | -$52.9K | 0.62% | 43 |
|
|
2016
Q2 | $2.14M | Buy |
34,592
+1,596
| +5% | +$97.3K | 0.61% | 44 |
|
|
2016
Q1 | $1.89M | Buy |
32,996
+9,949
| +43% | +$555K | 0.55% | 47 |
|
|
2015
Q4 | $1.36M | Buy |
23,047
+514
| +2% | +$29.6K | 0.42% | 70 |
|
|
2015
Q3 | $1.23M | Buy |
22,533
+530
| +2% | +$34.5K | 0.39% | 75 |
|
|
2015
Q2 | $1.48M | Buy |
22,003
+1,832
| +9% | +$120K | 0.43% | 63 |
|
|
2015
Q1 | $1.18M | Buy |
20,171
+705
| +4% | +$42.6K | 0.35% | 75 |
|
|
2014
Q4 | $1.27M | Buy |
19,466
+171
| +0.9% | +$10.8K | 0.41% | 70 |
|
|
2014
Q3 | $1.11M | Buy |
19,295
+545
| +3% | +$30.3K | 0.37% | 72 |
|
|
2014
Q2 | $1.06M | Sell |
18,750
-341
| -2% | -$17.9K | 0.35% | 73 |
|
|
2014
Q1 | $981K | Sell |
19,091
-566
| -3% | -$28.6K | 0.33% | 75 |
|
|
2013
Q4 | $1.04M | Sell |
19,657
-100
| -0.5% | -$4.92K | 0.37% | 67 |
|
|
2013
Q3 | $884K | Buy |
19,757
+185
| +0.9% | +$8.2K | 0.34% | 75 |
|
|
2013
Q2 | $809K | Buy |
+19,572
| New | +$856K | 0.32% | 78 |
|
Other funds holding ABBV
ECSS
ATO
Canandaigua National Bank & Trust's ABBV Position: Q2 2026 in Review
Canandaigua National Bank & Trust opened a new position in AbbVie (ABBV) in Q2 2026: 27,540 shares worth $6.93M. The stake represents 0.58% of the portfolio and ranks #36 among its holdings. This is a return to the name: Canandaigua National Bank & Trust previously reported a position in ABBV as recently as Q4 2025.
Canandaigua National Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 41 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Canandaigua National Bank & Trust held 27,540 shares of AbbVie worth $6.93M as of Q2 2026.
- AbbVie was a new Canandaigua National Bank & Trust position in Q2 2026.
- AbbVie made up 0.58% of Canandaigua National Bank & Trust's portfolio in Q2 2026, its #36 holding.
- Canandaigua National Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 41 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Canandaigua National Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.